Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
Is a |
Aspirin compound preparation (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Aspirin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
Is a |
Product containing aspirin and papaveretum (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Opium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Papaveretum (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
Has manufactured dose form |
Conventional release oral tablet (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
Is a |
Oral aspirin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
Has manufactured dose form |
Dispersible table |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
Has manufactured dose form |
Tablet for conventional release oral suspension (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|